ATE70534T1 - 2,3-dihydrobenzofuran-5-sulfonamid-derivate. - Google Patents
2,3-dihydrobenzofuran-5-sulfonamid-derivate.Info
- Publication number
- ATE70534T1 ATE70534T1 AT85110250T AT85110250T ATE70534T1 AT E70534 T1 ATE70534 T1 AT E70534T1 AT 85110250 T AT85110250 T AT 85110250T AT 85110250 T AT85110250 T AT 85110250T AT E70534 T1 ATE70534 T1 AT E70534T1
- Authority
- AT
- Austria
- Prior art keywords
- dihydrobenzofuran
- sulfonamide derivatives
- parenterally
- classified
- effects
- Prior art date
Links
- YSWWLKULIVOPEP-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-5-sulfonimidic acid Chemical class NS(=O)(=O)C1=CC=C2OCCC2=C1 YSWWLKULIVOPEP-UHFFFAOYSA-N 0.000 title abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000002171 loop diuretic Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59186971A JPS6163671A (ja) | 1984-09-05 | 1984-09-05 | 2,3−ジヒドロベンゾフラン−5−スルホンアミド誘導体および降圧利尿剤 |
EP85110250A EP0173899B1 (de) | 1984-09-05 | 1985-08-16 | 2,3-Dihydrobenzofuran-5-sulfonamid-Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE70534T1 true ATE70534T1 (de) | 1992-01-15 |
Family
ID=16197928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85110250T ATE70534T1 (de) | 1984-09-05 | 1985-08-16 | 2,3-dihydrobenzofuran-5-sulfonamid-derivate. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4659709A (de) |
EP (1) | EP0173899B1 (de) |
JP (1) | JPS6163671A (de) |
KR (1) | KR930002100B1 (de) |
AT (1) | ATE70534T1 (de) |
AU (1) | AU592060B2 (de) |
CA (1) | CA1265800A (de) |
DE (1) | DE3584919D1 (de) |
DK (1) | DK165954C (de) |
GB (1) | GB2164039B (de) |
IE (1) | IE58911B1 (de) |
NO (1) | NO169487C (de) |
NZ (1) | NZ213197A (de) |
PT (1) | PT81033B (de) |
ZA (1) | ZA856277B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116874A (en) * | 1985-09-23 | 1992-05-26 | Eli Lilly And Company | Anti-tumor method and compounds |
JPH01100164A (ja) * | 1987-10-12 | 1989-04-18 | Shionogi & Co Ltd | スルファモイル−2−ベンゾフランカルボン酸誘導体 |
DE3861963D1 (de) * | 1987-12-24 | 1991-04-11 | Boehringer Mannheim Gmbh | Heterocyclisch substituierte alkylsulfonamide, verfahren zu ihrer herstellung sowie arzneimittel. |
GB9110636D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
US5254582A (en) * | 1992-02-05 | 1993-10-19 | Eli Lilly And Company | Antitumor compositions and methods |
US5387681A (en) * | 1992-08-19 | 1995-02-07 | Eli Lilly And Company | Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and sulfonamides |
US6150402A (en) * | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
DE10135499A1 (de) * | 2001-07-20 | 2003-01-30 | Merck Patent Gmbh | Indanverbindungen mit negativem Delta-epsilon |
US7795242B2 (en) * | 2003-10-15 | 2010-09-14 | The Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
EP1805158B1 (de) | 2004-10-29 | 2018-06-27 | Kalypsys, Inc. | Sulfonyl-substituierte bizyklische verbindungen als ppar-modulatoren |
WO2007051095A1 (en) | 2005-10-25 | 2007-05-03 | Kalypsys, Inc. | Salts of modulators of ppar and methods of treating metabolic disorders |
US20080176861A1 (en) | 2007-01-23 | 2008-07-24 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6004073A (en) * | 1972-09-09 | 1975-03-06 | Basf Ag | Fluorescent benzofuran compounds |
US4401669A (en) * | 1978-01-27 | 1983-08-30 | Merck & Co., Inc. | 2,3-Dihydro-substituted-5-benzoyl benzofuran-2-carboxylic acids and their use in treating hypertension |
CA1145758A (en) * | 1979-05-16 | 1983-05-03 | Shell Canada Limited | 2,3-dihydro-2-benzofurancarboxamide derivatives |
US4237130A (en) * | 1979-06-21 | 1980-12-02 | Merck & Co., Inc. | 2,3-Dihydro-6,7-disubstituted-5-(substituted sulfonyl)benzofuran-2-carboxylic acids |
DE3317884A1 (de) * | 1983-05-17 | 1984-11-22 | Hoechst Ag, 6230 Frankfurt | 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung |
US4544667A (en) * | 1984-02-09 | 1985-10-01 | Merck & Co., Inc. | 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure |
-
1984
- 1984-09-05 JP JP59186971A patent/JPS6163671A/ja active Granted
-
1985
- 1985-08-12 US US06/764,785 patent/US4659709A/en not_active Expired - Lifetime
- 1985-08-13 CA CA000488588A patent/CA1265800A/en not_active Expired - Fee Related
- 1985-08-15 AU AU46215/85A patent/AU592060B2/en not_active Ceased
- 1985-08-16 DE DE8585110250T patent/DE3584919D1/de not_active Expired - Fee Related
- 1985-08-16 AT AT85110250T patent/ATE70534T1/de not_active IP Right Cessation
- 1985-08-16 EP EP85110250A patent/EP0173899B1/de not_active Expired - Lifetime
- 1985-08-19 ZA ZA856277A patent/ZA856277B/xx unknown
- 1985-08-22 NZ NZ213197A patent/NZ213197A/xx unknown
- 1985-08-27 PT PT81033A patent/PT81033B/pt not_active IP Right Cessation
- 1985-09-02 NO NO853441A patent/NO169487C/no unknown
- 1985-09-04 IE IE218885A patent/IE58911B1/en not_active IP Right Cessation
- 1985-09-04 GB GB08521967A patent/GB2164039B/en not_active Expired
- 1985-09-04 KR KR1019850006459A patent/KR930002100B1/ko not_active IP Right Cessation
- 1985-09-04 DK DK403185A patent/DK165954C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO169487B (no) | 1992-03-23 |
PT81033A (en) | 1985-09-01 |
GB8521967D0 (en) | 1985-10-09 |
US4659709A (en) | 1987-04-21 |
AU592060B2 (en) | 1990-01-04 |
ZA856277B (en) | 1986-04-30 |
JPH0354945B2 (de) | 1991-08-21 |
IE58911B1 (en) | 1993-12-01 |
AU4621585A (en) | 1986-03-13 |
DK165954B (da) | 1993-02-15 |
EP0173899A3 (en) | 1988-07-20 |
GB2164039B (en) | 1988-05-18 |
EP0173899B1 (de) | 1991-12-18 |
NZ213197A (en) | 1989-01-06 |
NO853441L (no) | 1986-03-06 |
DK403185A (da) | 1986-03-06 |
PT81033B (pt) | 1987-09-18 |
KR930002100B1 (ko) | 1993-03-26 |
CA1265800A (en) | 1990-02-13 |
DK165954C (da) | 1993-07-05 |
EP0173899A2 (de) | 1986-03-12 |
DK403185D0 (da) | 1985-09-04 |
NO169487C (no) | 1992-07-01 |
GB2164039A (en) | 1986-03-12 |
JPS6163671A (ja) | 1986-04-01 |
KR860002490A (ko) | 1986-04-26 |
IE852188L (en) | 1986-03-05 |
DE3584919D1 (de) | 1992-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE70534T1 (de) | 2,3-dihydrobenzofuran-5-sulfonamid-derivate. | |
IT1164548B (it) | Forme galeniche di somministrazione di medicamenti per via orale,a liberazione programmata,e loro procedimenti di preparazione | |
ATE81858T1 (de) | 6-thioxanthinderivate. | |
MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
SE9002500L (sv) | Farmaceutisk, nac-innehaallande komposition foer oral administrering | |
GB1503675A (en) | Compositions based on pyrimidine derivatives and their use in the treatment of viral infections | |
DE69831576T2 (de) | Chromium/biotin behandlung von typ-ii diabetes | |
KR890006639A (ko) | 벤조티아진 디옥사이드 유도체 | |
KR910009267A (ko) | 우울증의 치료방법 | |
AU574978B2 (en) | Method for treatment of antidiuresis employing serine derivatives | |
ES2062236T3 (es) | Emulsion de agua en aceite. | |
IE832255L (en) | Treatment of herpes labialis. | |
MY100938A (en) | Arylkylimidazole derivatives. | |
FI834045A0 (fi) | Isokinolinfoerening | |
ES8801122A1 (es) | Un metodo para preparar tabletas que contienen un compuesto derivado de acido peroxidifosforico no toxico, soluble en agua y farmaceuticamente aceptable. | |
IT1224250B (it) | Associzione del depiprazolo con la morfina | |
GB1465794A (en) | Thiourea derivatives | |
ES2018387A6 (es) | Procedimiento de obtencion de un medicamento para inhibir la infeccion de celulas por virus hiv. | |
IE820676L (en) | Pharmaceutical preparation | |
SU1271520A1 (ru) | Иммуностимул тор | |
GB1442619A (en) | 3-phenoxypropylamine derivatives their preparation and use | |
FR2449452A1 (fr) | Nouveau medicament utile notamment comme diuretique et detoxicant, derive de l'acide galacturonique | |
Robb | Hellenic Plans Public Stock Offer for Greek--Soviet Alumina Project | |
FR2244501A1 (en) | 5-Chloro-3-formyl-2-methylindoles - with diuretic analgesic and antiinflammatory activity | |
Druzhinina et al. | Experimental study of the effects of some triodine-containing radiographic contrast substances on blood coagulation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |